Viking Therapeutics (VKTX) had the highest return between October 10, 2022 and January 10, 2023 by a mid-cap US stock, returning 216.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Viking Therapeutics (VKTX) | 10/10/2022 - 1/10/2023 | 216.32% |
RLX Technology (RLX) | 10/10/2022 - 1/10/2023 | 174.21% |
Sotera Health (SHC) | 10/10/2022 - 1/10/2023 | 146.43% |
Miniso Group Holding (MNSO) | 10/10/2022 - 1/10/2023 | 135.29% |
Kingsoft Cloud Holdings (KC) | 10/10/2022 - 1/10/2023 | 128.37% |
Pharvaris (PHVS) | 10/10/2022 - 1/10/2023 | 121.56% |
TG Therapeutics (TGTX) | 10/10/2022 - 1/10/2023 | 114.39% |
HUTCHMED DRC (HCM) | 10/10/2022 - 1/10/2023 | 109.11% |
Enliven Therapeutics (ELVN) | 10/10/2022 - 1/10/2023 | 101.73% |
F&G Annuities & Life (FG) | 10/10/2022 - 1/10/2023 | 100.5% |
Immunovant (IMVT) | 10/10/2022 - 1/10/2023 | 99.89% |
TAL Education (TAL) | 10/10/2022 - 1/10/2023 | 96.28% |
Oceaneering International (OII) | 10/10/2022 - 1/10/2023 | 95.17% |
Youdao (DAO) | 10/10/2022 - 1/10/2023 | 90.43% |
Tango Therapeutics (TNGX) | 10/10/2022 - 1/10/2023 | 88.26% |
Bilibili (BILI) | 10/10/2022 - 1/10/2023 | 88.1% |
Abercrombie & Fitch (ANF) | 10/10/2022 - 1/10/2023 | 82.06% |
Vipshop (VIPS) | 10/10/2022 - 1/10/2023 | 81% |
Pitney Bowes (PBI) | 10/10/2022 - 1/10/2023 | 80.86% |
Powell Industries (POWL) | 10/10/2022 - 1/10/2023 | 79.94% |
Transocean (RIG) | 10/10/2022 - 1/10/2023 | 76.72% |
Viridian Therapeutics (VRDN) | 10/10/2022 - 1/10/2023 | 76.53% |
Aehr Test Systems (AEHR) | 10/10/2022 - 1/10/2023 | 69.74% |
Modine Manufacturing (MOD) | 10/10/2022 - 1/10/2023 | 69.29% |
Pulse Biosciences (PLSE) | 10/10/2022 - 1/10/2023 | 68.16% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.